Lupus antibodies to the HMGB1 chromosomal protein

Epitope mapping and association with disease activity

Ayako Hayashi, Hiroko Nagafuchi, Ichiaki Ito, Koichi Hirota, Michiteru Yoshida, Shoichi Ozaki

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The high mobility group box 1 (HMGB1) protein is a non-histone chromosomal protein that acts as a potent proinflammatory cytokine when actively secreted from LPS- or TNF-activated macrophages, monocytes, and other cells. Anti-HMGB1/2 antibodies have been previously identified in sera from a high proportion of patients with autoimmune diseases. In this study, we examined anti-HMGB1 antibody titers in sera of patients with systemic rheumatic diseases and the correlations between the presence of anti-HMGB1 antibodies and disease activity in systemic lupus erythematosus (SLE) patients by enzyme-linked immunosorbent assay and western blotting. We detected increases in both the levels and the frequency of anti-HMGB1 antibodies in sera from SLE and polymyositis/ dermatomyositis (PM/DM) patients, and observed that the presence of anti-HMGB1 antibodies positively correlates with SLE disease activity index. Through epitope mapping, we found that multiple HMGB1 epitopes were recognised in SLE sera, with the major epitope mapping to box A. Another epitope, the joiner region of HMGB1, was preferentially recognized by SLE sera, but not by PM/DM sera. Collectively, these observations suggest that the presence of anti-HMGB1 antibodies correlates with disease activity in SLE patients.

Original languageEnglish (US)
Pages (from-to)283-292
Number of pages10
JournalModern Rheumatology
Volume19
Issue number3
DOIs
StatePublished - Feb 13 2009
Externally publishedYes

Fingerprint

HMGB1 Protein
Epitope Mapping
Systemic Lupus Erythematosus
Antibodies
Serum
Dermatomyositis
Epitopes
Non Histone Chromosomal Proteins
Rheumatic Diseases
Autoimmune Diseases
Monocytes
Western Blotting
Enzyme-Linked Immunosorbent Assay
Macrophages
Cytokines

Keywords

  • Autoantibody
  • Epitope
  • High mobility group box 1 (HMGB1)
  • Molecular mimicry
  • Systemic lupus erythematosus (SLE)

ASJC Scopus subject areas

  • Rheumatology

Cite this

Lupus antibodies to the HMGB1 chromosomal protein : Epitope mapping and association with disease activity. / Hayashi, Ayako; Nagafuchi, Hiroko; Ito, Ichiaki; Hirota, Koichi; Yoshida, Michiteru; Ozaki, Shoichi.

In: Modern Rheumatology, Vol. 19, No. 3, 13.02.2009, p. 283-292.

Research output: Contribution to journalArticle

Hayashi, Ayako ; Nagafuchi, Hiroko ; Ito, Ichiaki ; Hirota, Koichi ; Yoshida, Michiteru ; Ozaki, Shoichi. / Lupus antibodies to the HMGB1 chromosomal protein : Epitope mapping and association with disease activity. In: Modern Rheumatology. 2009 ; Vol. 19, No. 3. pp. 283-292.
@article{732e73c368404b389276c1484d01cd83,
title = "Lupus antibodies to the HMGB1 chromosomal protein: Epitope mapping and association with disease activity",
abstract = "The high mobility group box 1 (HMGB1) protein is a non-histone chromosomal protein that acts as a potent proinflammatory cytokine when actively secreted from LPS- or TNF-activated macrophages, monocytes, and other cells. Anti-HMGB1/2 antibodies have been previously identified in sera from a high proportion of patients with autoimmune diseases. In this study, we examined anti-HMGB1 antibody titers in sera of patients with systemic rheumatic diseases and the correlations between the presence of anti-HMGB1 antibodies and disease activity in systemic lupus erythematosus (SLE) patients by enzyme-linked immunosorbent assay and western blotting. We detected increases in both the levels and the frequency of anti-HMGB1 antibodies in sera from SLE and polymyositis/ dermatomyositis (PM/DM) patients, and observed that the presence of anti-HMGB1 antibodies positively correlates with SLE disease activity index. Through epitope mapping, we found that multiple HMGB1 epitopes were recognised in SLE sera, with the major epitope mapping to box A. Another epitope, the joiner region of HMGB1, was preferentially recognized by SLE sera, but not by PM/DM sera. Collectively, these observations suggest that the presence of anti-HMGB1 antibodies correlates with disease activity in SLE patients.",
keywords = "Autoantibody, Epitope, High mobility group box 1 (HMGB1), Molecular mimicry, Systemic lupus erythematosus (SLE)",
author = "Ayako Hayashi and Hiroko Nagafuchi and Ichiaki Ito and Koichi Hirota and Michiteru Yoshida and Shoichi Ozaki",
year = "2009",
month = "2",
day = "13",
doi = "10.1007/s10165-009-0151-7",
language = "English (US)",
volume = "19",
pages = "283--292",
journal = "Modern Rheumatology",
issn = "1439-7595",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Lupus antibodies to the HMGB1 chromosomal protein

T2 - Epitope mapping and association with disease activity

AU - Hayashi, Ayako

AU - Nagafuchi, Hiroko

AU - Ito, Ichiaki

AU - Hirota, Koichi

AU - Yoshida, Michiteru

AU - Ozaki, Shoichi

PY - 2009/2/13

Y1 - 2009/2/13

N2 - The high mobility group box 1 (HMGB1) protein is a non-histone chromosomal protein that acts as a potent proinflammatory cytokine when actively secreted from LPS- or TNF-activated macrophages, monocytes, and other cells. Anti-HMGB1/2 antibodies have been previously identified in sera from a high proportion of patients with autoimmune diseases. In this study, we examined anti-HMGB1 antibody titers in sera of patients with systemic rheumatic diseases and the correlations between the presence of anti-HMGB1 antibodies and disease activity in systemic lupus erythematosus (SLE) patients by enzyme-linked immunosorbent assay and western blotting. We detected increases in both the levels and the frequency of anti-HMGB1 antibodies in sera from SLE and polymyositis/ dermatomyositis (PM/DM) patients, and observed that the presence of anti-HMGB1 antibodies positively correlates with SLE disease activity index. Through epitope mapping, we found that multiple HMGB1 epitopes were recognised in SLE sera, with the major epitope mapping to box A. Another epitope, the joiner region of HMGB1, was preferentially recognized by SLE sera, but not by PM/DM sera. Collectively, these observations suggest that the presence of anti-HMGB1 antibodies correlates with disease activity in SLE patients.

AB - The high mobility group box 1 (HMGB1) protein is a non-histone chromosomal protein that acts as a potent proinflammatory cytokine when actively secreted from LPS- or TNF-activated macrophages, monocytes, and other cells. Anti-HMGB1/2 antibodies have been previously identified in sera from a high proportion of patients with autoimmune diseases. In this study, we examined anti-HMGB1 antibody titers in sera of patients with systemic rheumatic diseases and the correlations between the presence of anti-HMGB1 antibodies and disease activity in systemic lupus erythematosus (SLE) patients by enzyme-linked immunosorbent assay and western blotting. We detected increases in both the levels and the frequency of anti-HMGB1 antibodies in sera from SLE and polymyositis/ dermatomyositis (PM/DM) patients, and observed that the presence of anti-HMGB1 antibodies positively correlates with SLE disease activity index. Through epitope mapping, we found that multiple HMGB1 epitopes were recognised in SLE sera, with the major epitope mapping to box A. Another epitope, the joiner region of HMGB1, was preferentially recognized by SLE sera, but not by PM/DM sera. Collectively, these observations suggest that the presence of anti-HMGB1 antibodies correlates with disease activity in SLE patients.

KW - Autoantibody

KW - Epitope

KW - High mobility group box 1 (HMGB1)

KW - Molecular mimicry

KW - Systemic lupus erythematosus (SLE)

UR - http://www.scopus.com/inward/record.url?scp=67349282299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349282299&partnerID=8YFLogxK

U2 - 10.1007/s10165-009-0151-7

DO - 10.1007/s10165-009-0151-7

M3 - Article

VL - 19

SP - 283

EP - 292

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

IS - 3

ER -